Comparative Assessment of Lymph Node Micrometastasis in Cervical, Endometrial and Vulvar Cancer: Insights on the Real Time qRT-PCR Approach versus Immunohistochemistry, Employing Dual Molecular Markers
Figure 1
Immunohistochemical analysis of positive and negative control samples for CK19 and CA9 expression. (a) Lymph node positive for metastasis from a patient with cervical carcinoma, stained with the mouse anti-CK19 monoclonal antibody. (b) A case of clear cell renal carcinoma positive for expression of CA9, using the rabbit anti-CA9 polyclonal antibody. (c) Lymph node from patient IE-19 with endometrial carcinoma, negative for micrometastasis and stained with the anti-CK19 antibody. (d) Lymph node from patient IE-19 with endometrial carcinoma, negative for micrometastasis and stained with the anti-CA9 antibody.